Thursday, May 30, 2024 · SEC filings
What the smart money revealed on May 30
574 insider filings came in. We hid 71 planned (10b5-1) sellers and 360 people whose filings were routine, like grants and tax withholding.
Exelixis (EXEL) Director David Johnson bought $8.73M
425,000 shares on the open market. Not a grant or an option exercise.
FTAI Aviation (FTAI) CEO and Chairman Joseph Adams Jr. bought $4.84M
59,000 shares on the open market. Not a grant or an option exercise. Their past buys: 3 of 3 checked quarters beat the typical stock 6 months later.
Telos (TLS) Director Fredrick Schaufeld bought $1.12M
253,366 shares on the open market. Not a grant or an option exercise.
Versus Capital Infrastructure Income Fund (VCRDX) CEO Mark Quam bought $750K
73,672 shares on the open market. Not a grant or an option exercise.
Inhibrx (INBX) Chief Scientific Officer Brendan Eckelman sold $10.3M
Not marked as a planned 10b5-1 sale. Sold 15% of the shares they held directly. Still holds 1.74M shares.
Kontoor Brands (KTB) Chair Scott Baxter sold $7.9M
Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 318,188 shares directly.
ICU Medical (ICUI) COO Christian Voigtlander sold $1.3M
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 62 more real buys
Show 54 more real sales
13F season
Holdings as of Mar 31, 2024 were due May 15
50 funds have filed. 49 filed for the quarter before.
Biggest real insider buys, May 24–30
Open-market buys by officers and directors, filed in the 7 days up to May 30.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.